Cortopassi W, Gunderson E, Annunciato Y, Silva A, Dos Santos Ferreira A, Teles C
Int J Parasitol Drugs Drug Resist. 2022; 20:121-128.
PMID: 36375339
PMC: 9771834.
DOI: 10.1016/j.ijpddr.2022.10.003.
Maher S, Vantaux A, Chaumeau V, Chua A, Cooper C, Andolina C
Sci Rep. 2021; 11(1):19905.
PMID: 34620901
PMC: 8497498.
DOI: 10.1038/s41598-021-99152-9.
Tumwebaze P, Katairo T, Okitwi M, Byaruhanga O, Orena S, Asua V
Lancet Microbe. 2021; 2(9):e441-e449.
PMID: 34553183
PMC: 8454895.
DOI: 10.1016/s2666-5247(21)00085-9.
Korkor C, Garnie L, Amod L, Egan T, Chibale K
Org Biomol Chem. 2020; 18(42):8668-8676.
PMID: 33078179
PMC: 7710849.
DOI: 10.1039/d0ob01730b.
Liebman K, Burgess S, Gunsaru B, Kelly J, Li Y, Morrill W
Molecules. 2020; 25(9).
PMID: 32397659
PMC: 7249153.
DOI: 10.3390/molecules25092251.
Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivatives.
Guillon J, Cohen A, Boudot C, Valle A, Milano V, Nath Das R
J Enzyme Inhib Med Chem. 2020; 35(1):432-459.
PMID: 31899980
PMC: 6968685.
DOI: 10.1080/14756366.2019.1706502.
Recent updates in the discovery and development of novel antimalarial drug candidates.
Okombo J, Chibale K
Medchemcomm. 2018; 9(3):437-453.
PMID: 30108934
PMC: 6071755.
DOI: 10.1039/c7md00637c.
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.
Basilico N, Parapini S, Sparatore A, Romeo S, Misiano P, Vivas L
Molecules. 2017; 22(12).
PMID: 29194347
PMC: 6149971.
DOI: 10.3390/molecules22122102.
AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.
Koita O, Sangare L, Miller H, Sissako A, Coulibaly M, Thompson T
Lancet Infect Dis. 2017; 17(12):1266-1275.
PMID: 28916443
PMC: 5700806.
DOI: 10.1016/S1473-3099(17)30365-1.
Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives.
Guillon J, Cohen A, Gueddouda N, Nath Das R, Moreau S, Ronga L
J Enzyme Inhib Med Chem. 2017; 32(1):547-563.
PMID: 28114821
PMC: 6445168.
DOI: 10.1080/14756366.2016.1268608.
Clinical Research and the Training of Host Country Investigators: Essential Health Priorities for Disease-Endemic Regions.
Koita O, Murphy R, Fongoro S, Diallo B, Doumbia S, Traore M
Am J Trop Med Hyg. 2015; 94(2):253-257.
PMID: 26598570
PMC: 4751934.
DOI: 10.4269/ajtmh.15-0366.
Identification of β-hematin inhibitors in a high-throughput screening effort reveals scaffolds with in vitro antimalarial activity.
Sandlin R, Fong K, Wicht K, Carrell H, Egan T, Wright D
Int J Parasitol Drugs Drug Resist. 2014; 4(3):316-25.
PMID: 25516843
PMC: 4266794.
DOI: 10.1016/j.ijpddr.2014.08.002.
Characterization of the commercially-available fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a marker for chloroquine resistance and uptake in a 96-well plate assay.
Loh C, Suwanarusk R, Lee Y, Chan K, Choy K, Renia L
PLoS One. 2014; 9(10):e110800.
PMID: 25343249
PMC: 4208776.
DOI: 10.1371/journal.pone.0110800.
β-amino-alcohol tethered 4-aminoquinoline-isatin conjugates: synthesis and antimalarial evaluation.
Nisha , Gut J, Rosenthal P, Kumar V
Eur J Med Chem. 2014; 84:566-73.
PMID: 25062007
PMC: 7115587.
DOI: 10.1016/j.ejmech.2014.07.064.
8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications.
Prachayasittikul V, Prachayasittikul S, Ruchirawat S, Prachayasittikul V
Drug Des Devel Ther. 2013; 7:1157-78.
PMID: 24115839
PMC: 3793592.
DOI: 10.2147/DDDT.S49763.
Malaria biology and disease pathogenesis: insights for new treatments.
Miller L, Ackerman H, Su X, Wellems T
Nat Med. 2013; 19(2):156-67.
PMID: 23389616
PMC: 4783790.
DOI: 10.1038/nm.3073.
Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
Saenz F, Mutka T, Udenze K, Oduola A, Kyle D
Antimicrob Agents Chemother. 2012; 56(9):4685-92.
PMID: 22710117
PMC: 3421852.
DOI: 10.1128/AAC.01061-12.
Sontochin as a guide to the development of drugs against chloroquine-resistant malaria.
Pou S, Winter R, Nilsen A, Kelly J, Li Y, Doggett J
Antimicrob Agents Chemother. 2012; 56(7):3475-80.
PMID: 22508305
PMC: 3393441.
DOI: 10.1128/AAC.00100-12.
Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.
Summers R, Nash M, Martin R
Cell Mol Life Sci. 2012; 69(12):1967-95.
PMID: 22286067
PMC: 11115045.
DOI: 10.1007/s00018-011-0906-0.
4-aminoquinolines active against chloroquine-resistant Plasmodium falciparum: basis of antiparasite activity and quantitative structure-activity relationship analyses.
Hocart S, Liu H, Deng H, De D, Krogstad F, Krogstad D
Antimicrob Agents Chemother. 2011; 55(5):2233-44.
PMID: 21383099
PMC: 3088224.
DOI: 10.1128/AAC.00675-10.